Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

QMCPACK: an open source ab initio quantum Monte Carlo package for the electronic structure of atoms, molecules and solids.

Kim J, Baczewski AT, Beaudet TD, Benali A, Bennett MC, Berrill MA, Blunt NS, Borda EJL, Casula M, Ceperley DM, Chiesa S, Clark BK, Clay RC, Delaney KT, Dewing M, Esler KP, Hao H, Heinonen O, Kent PRC, Krogel JT, Kylänpää I, Li YW, Lopez MG, Luo Y, Malone FD, Martin RM, Mathuriya A, McMinis J, Melton CA, Mitas L, Morales MA, Neuscamman E, Parker WD, Pineda Flores SD, Romero NA, Rubenstein BM, Shea JAR, Shin H, Shulenburger L, Tillack AF, Townsend JP, Tubman NM, Van Der Goetz B, Vincent JE, Yang DC, Yang Y, Zhang S, Zhao L.

J Phys Condens Matter. 2018 May 16;30(19):195901. doi: 10.1088/1361-648X/aab9c3. Epub 2018 Mar 27.

PMID:
29582782
2.

Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer's Disease: Analysis of 13 Cases.

Chen Y, Liu C, Parker WD, Chen H, Beach TG, Liu X, Serrano GE, Lu Y, Huang J, Yang K, Wang C.

PLoS One. 2016 Jun 14;11(6):e0154582. doi: 10.1371/journal.pone.0154582. eCollection 2016.

3.

Aberrant mitochondrial RNA in the role of aging and aging associated diseases.

Chen Y, Parker WD, Chen H, Yang K.

Med Hypotheses. 2015 Aug;85(2):178-82. doi: 10.1016/j.mehy.2015.04.022. Epub 2015 Apr 28.

4.

The role of T-type calcium channel genes in absence seizures.

Chen Y, Parker WD, Wang K.

Front Neurol. 2014 May 9;5:45. doi: 10.3389/fneur.2014.00045. eCollection 2014. Review.

6.

Polymorphic variation in cytochrome oxidase subunit genes.

Lu J, Wang K, Rodova M, Esteves R, Berry D, E L, Crafter A, Barrett M, Cardoso SM, Onyango I, Parker WD, Fontes J, Burns JM, Swerdlow RH.

J Alzheimers Dis. 2010;21(1):141-54. doi: 10.3233/JAD-2010-100123.

7.

Complex I deficiency in Parkinson's disease frontal cortex.

Parker WD Jr, Parks JK, Swerdlow RH.

Brain Res. 2008 Jan 16;1189:215-8. Epub 2007 Nov 1.

8.

Effects of memantine on mitochondrial function.

McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH.

Biochem Pharmacol. 2008 Feb 15;75(4):956-64. Epub 2007 Oct 23.

9.

Retraction.

Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12069. No abstract available.

10.

Genetic algorithm for analysis of mutations in Parkinson's disease.

Smigrodzki R, Goertzel B, Pennachin C, Coelho L, Prosdocimi F, Parker WD Jr.

Artif Intell Med. 2005 Nov;35(3):227-41. Epub 2005 Oct 3.

PMID:
16207526
11.

Mitochondrial ND5 mutations in idiopathic Parkinson's disease.

Parker WD Jr, Parks JK.

Biochem Biophys Res Commun. 2005 Jan 21;326(3):667-9.

PMID:
15596151
12.

High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

Smigrodzki R, Parks J, Parker WD.

Neurobiol Aging. 2004 Nov-Dec;25(10):1273-81.

PMID:
15465623
13.

Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.

Trimmer PA, Borland MK, Keeney PM, Bennett JP Jr, Parker WD Jr.

J Neurochem. 2004 Feb;88(4):800-12.

14.

Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.

Trimmer PA, Keeney PM, Borland MK, Simon FA, Almeida J, Swerdlow RH, Parks JP, Parker WD Jr, Bennett JP Jr.

Neurobiol Dis. 2004 Feb;15(1):29-39.

PMID:
14751768
15.

Personality trait development from age 12 to age 18: longitudinal, cross-sectional, and cross-cultural analyses.

McCrae RR, Costa PT Jr, Terracciano A, Parker WD, Mills CJ, De Fruyt F, Mervielde I.

J Pers Soc Psychol. 2002 Dec;83(6):1456-68.

PMID:
12500824
16.

Cervical laminoforaminotomy.

Parker WD.

J Neurosurg. 2002 Mar;96(2 Suppl):254; author reply 254-5. No abstract available.

PMID:
12450291
17.

Role of mitochondria in amyotrophic lateral sclerosis.

Swerdlow RH, Parks JK, Pattee G, Parker WD Jr.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Jun;1(3):185-90. Review.

PMID:
11464951
18.

Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects.

Swerdlow RH, Parks JK, Cassarino DS, Binder DR, Bennett JP Jr, Di Iorio G, Golbe LI, Parker WD Jr.

Exp Neurol. 2001 Jun;169(2):479-85.

PMID:
11358461
19.

Gender ratio differences between Parkinson's disease patients and their affected relatives.

Swerdlow RH, Parker WD, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF.

Parkinsonism Relat Disord. 2001 Apr;7(2):129-133.

PMID:
11248594
21.

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy.

Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD Jr, Beal MF.

Exp Neurol. 2001 Mar;168(1):196-8.

PMID:
11170735
22.

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP Jr, Wooten GF, Parker WD.

J Neurochem. 2000 Oct;75(4):1681-4.

23.
24.

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC, Parks JK, Swerdlow RH, Parker WD Jr, Bennett JP Jr.

Ann Neurol. 2000 Aug;48(2):148-55.

PMID:
10939564
25.

Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease.

Cassarino DS, Halvorsen EM, Swerdlow RH, Abramova NN, Parker WD Jr, Sturgill TW, Bennett JP Jr.

J Neurochem. 2000 Apr;74(4):1384-92.

26.

Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE, Parker WD Jr.

Exp Neurol. 2000 Mar;162(1):37-50.

PMID:
10716887
27.

Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.

Ghosh SS, Swerdlow RH, Miller SW, Sheeman B, Parker WD Jr, Davis RE.

Ann N Y Acad Sci. 1999;893:176-91. Review.

PMID:
10672237
28.

Parkinson disease in twins.

Parker WD Jr, Swerdlow RH, Parks JK, Davis JN 2nd, Trimmer P, Bennett JP, Wooten GF.

JAMA. 1999 Oct 13;282(14):1328; author reply 1328-9. No abstract available.

PMID:
10527169
29.

Mitochondrial abnormalities in non-alcoholic steatohepatitis.

Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr.

J Hepatol. 1999 Sep;31(3):430-4.

PMID:
10488700
30.

Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.

Swerdlow RH, Parks JK, Cassarino DS, Shilling AT, Bennett JP Jr, Harrison MB, Parker WD Jr.

Biochem Biophys Res Commun. 1999 Aug 11;261(3):701-4.

PMID:
10441489
31.

The other genome.

Parker WD Jr.

Clin Chem. 1999 Aug;45(8 Pt 1):1129-30. No abstract available.

32.

Risk factors for schizophrenia.

Swerdlow RH, Binder D, Parker WD.

N Engl J Med. 1999 Jul 29;341(5):371-2; author reply 372. No abstract available.

PMID:
10428663
33.
34.

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family.

Swerdlow RH, Parks JK, Davis JN 2nd, Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP Jr, Wooten GF, Parker WD.

Ann Neurol. 1998 Dec;44(6):873-81.

PMID:
9851431
35.

Secondary inhibition of 2-ketoglutarate dehydrogenase complex by MPTP.

Joffe GT, Parks JK, Parker WD Jr.

Neuroreport. 1998 Aug 24;9(12):2781-3.

PMID:
9760120
36.

Mitochondria in sporadic amyotrophic lateral sclerosis.

Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP Jr, Davis RE, Parker WD Jr.

Exp Neurol. 1998 Sep;153(1):135-42.

PMID:
9743575
37.

Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.

Parsons DW, McAndrew PE, Allinson PS, Parker WD Jr, Burghes AH, Prior TW.

J Med Genet. 1998 Aug;35(8):674-6.

38.

Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids.

Cassarino DS, Swerdlow RH, Parks JK, Parker WD Jr, Bennett JP Jr.

Biochem Biophys Res Commun. 1998 Jul 9;248(1):168-73.

PMID:
9675105
39.

Mitochondrial dysfunction in idiopathic Parkinson disease.

Parker WD Jr, Swerdlow RH.

Am J Hum Genet. 1998 Apr;62(4):758-62. Review.

40.
41.

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.

Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD Jr, Bennett JP Jr.

Biochim Biophys Acta. 1997 Nov 28;1362(1):77-86.

42.

Cybrids in Alzheimer's disease: a cellular model of the disease?

Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP Jr, Davis RE, Parker WD Jr.

Neurology. 1997 Oct;49(4):918-25.

PMID:
9339668
43.

Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease.

Fahy E, Nazarbaghi R, Zomorrodi M, Herrnstadt C, Parker WD, Davis RE, Ghosh SS.

Nucleic Acids Res. 1997 Aug 1;25(15):3102-9.

44.

Outpatient surgical treatment of cervical radiculopathy.

Tomaras CR, Blacklock JB, Parker WD, Harper RL.

J Neurosurg. 1997 Jul;87(1):41-3.

PMID:
9202263
45.

Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.

Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB.

J Neurosci. 1997 Jun 15;17(12):4612-22.

46.

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease.

Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD Jr.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4526-31. Retraction in: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12069.

47.

Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease.

Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB.

J Neurochem. 1997 Mar;68(3):1221-33.

48.

Maternal inheritance in Parkinson's disease.

Wooten GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Parker WD Jr.

Ann Neurol. 1997 Feb;41(2):265-8.

PMID:
9029076
49.

Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties.

Miller SW, Trimmer PA, Parker WD Jr, Davis RE.

J Neurochem. 1996 Nov;67(5):1897-907.

PMID:
8863494
50.

Origin and functional consequences of the complex I defect in Parkinson's disease.

Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE, Parker WD Jr.

Ann Neurol. 1996 Oct;40(4):663-71.

PMID:
8871587

Supplemental Content

Loading ...
Support Center